knowledge -WSS

knowledge

author：Wikipedia 2025-09-28 02:32:41 - browse：5348

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Medicare to cover more brain scans for Alzheimer’s patients

hotspot

leisure time

WSS

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Startup Neumora takes a novel depression drug to Phase 3

HHS names first

Three issues to watch in global health in 2024

How Medicaid coverage policies for immigrants impact new moms

Startup Neumora takes a novel depression drug to Phase 3

focus

knowledge

focus

Psychedelics group wrestles with new pharma identity

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Bright Health sells Medicare Advantage business to Molina

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Duchenne breakthrough therapy leaves behind pioneering families

Fauci’s Covid grilling leads GOP to weigh foreign research rules

BioMarin wins approval for gene therapy to treat hemophilia A

New Medicare drug pricing powers could soon be upended in court

Virginia high school admissions case could be legal follow

Risky weight loss products often used by teens globally, per study

focus

Fauci’s Covid grilling leads GOP to weigh foreign research rules

FDA approves RSV monoclonal antibody for infants, toddlers

In early work, researchers turn to CRISPR to treat Alzheimer's

How I ended up pumping milk in a bathroom stall at JPM 2024

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

hotspot

Wikipedia

leisure time

focus